Drug intelligence / Profile preview

tixocortol pivalate

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intranasal, Oral, Rectal
01

Overview

**Tixocortol pivalate** is a synthetic corticosteroid and 21-thiol derivative of hydrocortisone classified as a class A steroid, featuring topical anti-inflammatory properties with minimal systemic glucocorticoid or mineralocorticoid activity due to rapid liver metabolism and transformation in red blood cells. It acts as a glucocorticoid receptor agonist and histone deacetylase 2 stimulator, reducing inflammation locally in conditions like rhinitis, pharyngitis, and ulcerative colitis. Primarily administered via nasal sprays, lozenges, enemas, or rectal solutions, it is also used in patch testing to screen for contact allergies to class A corticosteroids and is marketed under names like Pivalone.[1][2][3][4][5][6][7]

Brand names
PivaloneProcolonRectovaloneTivalon-NTTiprederm
Other names
11beta,17-Dihydroxy-21-mercaptopregn-4-ene-3,20-dione 21-pivalate(11beta)-21-[(2,2-dimethyl-1-oxo-propyl)thio]-11,17-dihydroxypregn-4-ene-3,20-dioneT-031T031T 031T-031AT031AT 031A
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on tixocortol pivalate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tixocortol pivalate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call